{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:47:56Z","timestamp":1790315276519,"version":"4.1.0"},"reference-count":39,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013297","name":"Icelandic Technical Development Fund","doi-asserted-by":"publisher","award":["114744"],"award-info":[{"award-number":["114744"]}],"id":[{"id":"10.13039\/100013297","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Background\/Objectives: Ulcerative colitis (UC) is an inflammatory bowel disease and a major cause of ulcers and chronic inflammation in the colon and rectum. Recurring symptoms include abdominal pain, rectal bleeding, and diarrhoea, and patients with UC are at a higher risk of developing comorbidities such as colorectal cancer and poor mental health. In UC, the decreased diversity and changed metabolic profile of gut microbiota, along with a diminished mucus layer, leads to disruption of the underlying epithelial barrier, with an ensuing excessive and detrimental inflammatory response. Treatment options currently rely on drugs that reduce the inflammation, but less emphasis has been placed on improving the resilience of the epithelial barrier. Macrolide antibiotics exhibit epithelial barrier-enhancing capacities unrelated to their antibacterial properties. Methods: We investigated two novel barriolides, macrolides with reduced antibacterial effects in common bacterial strains. Gut epithelial cell barrier resistance in the Caco-2 cell line, with and without co-culture with mucus-producing HT-29 cells, was increased when treated with barriolides. Using AXGut-on-Chip technology with inflammatory cytokine-stimulated Caco-2\/HT-29 co-cultures, the effectiveness of the barriolides was confirmed. Lastly, we reveal the barrier-enhancing and inflammation-reducing effects of the barriolides in a dextran-sulphate sodium (DSS)-induced colitis mouse model. Results: We show the predictive power of the novel AXGut-on-Chip system and the effectiveness of the novel barriolides. Indications include reduced inflammatory response, increased epithelial barrier and decreased overall clinical score. Conclusions: The results of this study indicate the notion that barriolides could be used as a treatment option for UC.<\/jats:p>","DOI":"10.3390\/biomedicines14010237","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T11:11:17Z","timestamp":1768993877000},"page":"237","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["In Vitro and In Vivo Efficacy of Epithelial Barrier-Promoting Barriolides as Potential Therapy for Ulcerative Colitis"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3261-4504","authenticated-orcid":false,"given":"Jon","family":"Joelsson","sequence":"first","affiliation":[{"name":"EpiEndo Pharmaceuticals ehf., Bjargargata 1, 102 Reykjav\u00edk, Iceland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7098-8451","authenticated-orcid":false,"given":"Michael","family":"Parnham","sequence":"additional","affiliation":[{"name":"EpiEndo Pharmaceuticals ehf., Bjargargata 1, 102 Reykjav\u00edk, Iceland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laur\u00e8ne","family":"Froment","sequence":"additional","affiliation":[{"name":"AlveoliX AG, Swiss Organs-on-Chip Innovation, 3010 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude","family":"Rapet","sequence":"additional","affiliation":[{"name":"AlveoliX AG, Swiss Organs-on-Chip Innovation, 3010 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Hugi","sequence":"additional","affiliation":[{"name":"AlveoliX AG, Swiss Organs-on-Chip Innovation, 3010 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janick","family":"Stucki","sequence":"additional","affiliation":[{"name":"AlveoliX AG, Swiss Organs-on-Chip Innovation, 3010 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Hobi","sequence":"additional","affiliation":[{"name":"AlveoliX AG, Swiss Organs-on-Chip Innovation, 3010 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0757-1936","authenticated-orcid":false,"given":"Jennifer","family":"Kricker","sequence":"additional","affiliation":[{"name":"EpiEndo Pharmaceuticals ehf., Bjargargata 1, 102 Reykjav\u00edk, Iceland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.gtc.2020.07.005","article-title":"Epidemiology and Pathogenesis of Ulcerative Colitis","volume":"49","author":"Du","year":"2020","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","article-title":"Ulcerative colitis","volume":"402","author":"Honap","year":"2023","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"jjaf091","DOI":"10.1093\/ecco-jcc\/jjaf091","article-title":"Cancer incidence in patients with ulcerative colitis naive to or treated with thiopurine and targeted therapies-a cohort study 2007 to 2022 with comparison to the general population","volume":"19","author":"Everhov","year":"2025","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"22641","DOI":"10.1038\/s41598-025-05108-8","article-title":"Oxidative stress gene expression in ulcerative colitis: Implications for colon cancer biomarker discovery","volume":"15","author":"Yan","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"100851","DOI":"10.1016\/j.disamonth.2019.02.004","article-title":"A comprehensive review and update on ulcerative colitis","volume":"65","author":"Gajendran","year":"2019","journal-title":"Dis. Mon."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrgastro.2016.169","article-title":"The intestinal epithelial barrier: A therapeutic target?","volume":"14","author":"Odenwald","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"17562848221138160","DOI":"10.1177\/17562848221138160","article-title":"A review of the therapeutic management of ulcerative colitis","volume":"15","author":"Aslam","year":"2022","journal-title":"Therap. Adv. Gastroenterol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev-med-052919-120048","article-title":"New Therapeutics for Ulcerative Colitis","volume":"72","author":"Hirten","year":"2021","journal-title":"Annu. Rev. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"105643","DOI":"10.1016\/j.jbc.2024.105643","article-title":"Mechanisms underlying distinct subcellular localization and regulation of epithelial long myosin light-chain kinase splice variants","volume":"300","author":"Abtahi","year":"2024","journal-title":"J. Biol. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/s41591-019-0393-7","article-title":"Intracellular MLCK1 diversion reverses barrier loss to restore mucosal homeostasis","volume":"25","author":"Graham","year":"2019","journal-title":"Nat. Med."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"He, W.Q., Wang, J., Sheng, J.Y., Zha, J.M., Graham, W.V., and Turner, J.R. (2020). Contributions of Myosin Light Chain Kinase to Regulation of Epithelial Paracellular Permeability and Mucosal Homeostasis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21030993"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1093\/ibd\/izab034","article-title":"Liver X Receptor Exerts Anti-Inflammatory Effects in Colonic Epithelial Cells via ABCA1 and Its Expression Is Decreased in Human and Experimental Inflammatory Bowel Disease","volume":"27","author":"Puerto","year":"2021","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Pellegrino, R., Imperio, G., De Costanzo, I., Izzo, M., Landa, F., Tambaro, A., Gravina, A.G., and Federico, A. (2025). Small Molecules in the Treatment of Acute Severe Ulcerative Colitis: A Review of Current Evidence. Pharmaceuticals, 18.","DOI":"10.3390\/ph18030308"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"102363","DOI":"10.1016\/j.pupt.2025.102363","article-title":"A novel macrolide, EP395, with reduced antibacterial activity and an enhancing effect on respiratory epithelial barrier","volume":"90","author":"Gudjonsson","year":"2025","journal-title":"Pulm. Pharmacol. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"102364","DOI":"10.1016\/j.pupt.2025.102364","article-title":"Effects of EP395, a novel macrolide, on acute neutrophilic airway inflammation","volume":"90","author":"Kricker","year":"2025","journal-title":"Pulm. Pharmacol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.14573\/altex.1510051","article-title":"Non-animal models of epithelial barriers (skin, intestine and lung) in research, industrial applications and regulatory toxicology","volume":"32","author":"Gordon","year":"2015","journal-title":"ALTEX"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s44164-022-00035-8","article-title":"Inflammatory bowel disease addressed by Caco-2 and monocyte-derived macrophages: An opportunity for an in vitro drug screening assay","volume":"1","author":"Schnur","year":"2022","journal-title":"In Vitro Models"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e2302454","DOI":"10.1002\/adhm.202302454","article-title":"A Versatile Intestine-on-Chip System for Deciphering the Immunopathogenesis of Inflammatory Bowel Disease","volume":"13","author":"Nguyen","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e10715","DOI":"10.1002\/btm2.10715","article-title":"A stretchable human lung-on-chip model of alveolar inflammation for evaluating anti-inflammatory drug response","volume":"10","author":"Richter","year":"2025","journal-title":"Bioeng. Transl. Med."},{"key":"ref_20","first-page":"1341","article-title":"Animal models of ulcerative colitis and their application in drug research","volume":"7","author":"Low","year":"2013","journal-title":"Drug Des. Devel Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/ibd\/izad312","article-title":"Unveiling Colitis: A Journey through the Dextran Sodium Sulfate-induced Model","volume":"30","author":"Yang","year":"2024","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Sengupta, A., Dorn, A., Jamshidi, M., Schwob, M., Hassan, W., De Maddalena, L.L., Hugi, A., Stucki, A.O., Dorn, P., and Marti, T.M. (2023). A multiplex inhalation platform to model in situ like aerosol delivery in a breathing lung-on-chip. Front. Pharmacol., 14, Erratum in Front. Pharmacol. 2023, 14, 1229313.","DOI":"10.3389\/fphar.2023.1114739"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12931-019-1101-3","article-title":"Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia","volume":"20","author":"Arason","year":"2019","journal-title":"Respir. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s12931-020-01489-8","article-title":"Azithromycin ameliorates sulfur dioxide-induced airway epithelial damage and inflammatory responses","volume":"21","author":"Joelsson","year":"2020","journal-title":"Respir. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.archoralbio.2015.11.015","article-title":"Azithromycin recovers reductions in barrier function in human gingival epithelial cells stimulated with tumor necrosis factor-alpha","volume":"62","author":"Miyagawa","year":"2016","journal-title":"Arch. Oral Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e12960","DOI":"10.14814\/phy2.12960","article-title":"The differential effects of azithromycin on the airway epithelium in vitro and in vivo","volume":"4","author":"Slater","year":"2016","journal-title":"Physiol. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"115005","DOI":"10.1016\/j.biopha.2023.115005","article-title":"The immunomodulatory effects of probiotics and azithromycin in dextran sodium sulfate-induced ulcerative colitis in rats via TLR4-NF-kappaB and p38-MAPK pathway","volume":"165","author":"Elkholy","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.taap.2004.09.012","article-title":"Azithromycin and erythromycin ameliorate the extent of colonic damage induced by acetic acid in rats","volume":"205","author":"Mahgoub","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3109\/09637486.2015.1077792","article-title":"Optimization of Caco-2 and HT29 co-culture in vitro cell models for permeability studies","volume":"66","author":"Pan","year":"2015","journal-title":"Int. J. Food Sci. Nutr."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"128497","DOI":"10.1016\/j.chemosphere.2020.128497","article-title":"Co-culture model of Caco-2\/HT29-MTX cells: A promising tool for investigation of phycotoxins toxicity on the intestinal barrier","volume":"273","author":"Reale","year":"2020","journal-title":"Chemosphere"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Hoffmann, P., Burmester, M., Langeheine, M., Brehm, R., Empl, M.T., Seeger, B., and Breves, G. (2021). Caco-2\/HT29-MTX co-cultured cells as a model for studying physiological properties and toxin-induced effects on intestinal cells. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0257824"},{"key":"ref_32","unstructured":"FDA (2025). FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1038\/s41467-024-47062-5","article-title":"The physiological interactome of TCR-like antibody therapeutics in human tissues","volume":"15","author":"Nicastri","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2200030","DOI":"10.1002\/adtp.202200030","article-title":"Classical Complement Pathway Inhibition in a \u201cHuman-On-A-Chip\u201d Model of Autoimmune Demyelinating Neuropathies","volume":"5","author":"Rumsey","year":"2022","journal-title":"Adv. Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/02611929241310566","article-title":"The Use of MPS in Three Rs and Regulatory Applications: Perspectives From Developers on Stakeholder Responsibilities","volume":"53","author":"LaFollette","year":"2025","journal-title":"Altern. Lab. Anim."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Rimmer, C., Hetelekides, S., Eliseeva, S.I., Georas, S.N., and Veazey, J.M. (2024). Correction: Budesonide promotes airway epithelial barrier integrity following double-stranded RNA challenge. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0306666"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.intimp.2011.12.006","article-title":"Glucocorticoids enhance airway epithelial barrier integrity","volume":"12","author":"Sekiyama","year":"2012","journal-title":"Int. Immunopharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.30802\/AALAS-CM-18-000001","article-title":"Effects of Azithromycin on Behavior, Pathologic Signs, and Changes in Cytokines, Chemokines, and Neutrophil Migration in C57BL\/6 Mice Exposed to Dextran Sulfate Sodium","volume":"69","author":"Anderson","year":"2019","journal-title":"Comp. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1080\/17474124.2021.1940956","article-title":"Antibiotics in pediatric inflammatory bowel diseases: A systematic review","volume":"15","author":"Verburgt","year":"2021","journal-title":"Expert. Rev. Gastroenterol. Hepatol."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/14\/1\/237\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T09:40:56Z","timestamp":1769506856000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/14\/1\/237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["biomedicines14010237"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines14010237","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]}}}